End-stage cystic fibrosis lung disease is characterised by a diverse inflammatory pattern: An immunohistochemical analysis

Respiratory Research

Volumn 18, Issue 1, 2017, Pages

  Lammertyn, Elise J ^a   Vandermeulen, Elly ^a   Bellon, Hannelore ^a   Everaerts, Stephanie ^a   Verleden, Stijn E ^a   Van Den Eynde, Kathleen ^b   Bracke, Ken R ^c   Brusselle, Guy G ^c   Goeminne, Pieter C ^a   Verbeken, Erik K ^b   Vanaudenaerde, Bart M ^a   Dupont, Lieven J ^d  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b DEPARTMENT OF IMAGING AND PATHOLOGY   (Belgium)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Cellular immune system; Histopathology; Lung immunopathology

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; CORTICOSTEROID; LANGERIN; T6 ANTIGEN; AUTACOID;

ADAPTIVE IMMUNITY; ADULT; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; EOSINOPHIL; EOSINOPHIL COUNT; FEMALE; FORCED EXPIRATORY VOLUME; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; INNATE IMMUNITY; LUNG FIBROSIS; LUNG PARENCHYMA; LUNG TRANSPLANTATION; LYMPH FOLLICLE; LYMPHOID CELL; MACROPHAGE; MALE; MAST CELL; NEUTROPHIL; NEUTROPHIL COUNT; NOSE POLYP; RESPIRATORY TRACT INFLAMMATION; CYSTIC FIBROSIS; IMMUNOLOGY; LUNG; MIDDLE AGED; PATHOLOGY; PNEUMONIA; SEXUAL CHARACTERISTICS; T LYMPHOCYTE;

CYSTIC FIBROSIS; FEMALE; HUMANS; INFLAMMATION MEDIATORS; LUNG; MACROPHAGES; MALE; MIDDLE AGED; PNEUMONIA; SEX CHARACTERISTICS; T-LYMPHOCYTES;

EID: 85008501979     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/s12931-016-0489-2     Document Type: Article

References (24)

1. Davis PB, Drumm M, Konstan MW. Cystic fibrosis. Am J Respir Crit Care Med. 1996;154(5):1229-56.
2. Welsh MJ, Fick RB. Cystic fibrosis. J Clin Invest. 1987;80(6):1523-6.
3. Cohen-Cymberknoh M, Kerem E, Ferkol T, Elizur A. Airway inflammation in cystic fibrosis: molecular mechanisms and clinical implications. Thorax. 2013;68(12):1157-62.
4. Stoltz DA, Meyerholz DK, Welsh MJ. Origins of cystic fibrosis lung disease. N Engl J Med. 2015;372(16):1574-5.
5. Watt AP, Courtney J, Moore J, Ennis M, Elborn JS. Neutrophil cell death, activation and bacterial infection in cystic fibrosis. Thorax. 2005;60(8):659-64.
6. Braun AT, Merlo CA. Cystic fibrosis lung transplantation. Curr Opin Pulm Med. 2011;17(6):467-72.
7. Yonker LM, Cigana C, Hurley BP, Bragonzi A. Host-pathogen interplay in the respiratory environment of cystic fibrosis. J Cyst Fibros. 2015;14(4):431-9.
8. Hartl D, Gaggar A, Bruscia E, Hector A, Marcos V, Jung A, et al. Innate immunity in cystic fibrosis lung disease. J Cyst Fibros. 2012;11(5):363-82.
9. Andersson CK, Andersson-Sjoland A, Mori M, Hallgren O, Pardo A, Eriksson L, et al. Activated MCTC mast cells infiltrate diseased lung areas in cystic fibrosis and idiopathic pulmonary fibrosis. Respir Res. 2011;12:139.
10. Azzawi M, Johnston PW, Majumdar S, Kay AB, Jeffery PK. T lymphocytes and activated eosinophils in airway mucosa in fatal asthma and cystic fibrosis. Am Rev Respir Dis. 1992;145(6):1477-82.
11. Hausler M, Schweizer K, Biesterfel S, Opladen T, Heimann G. Peripheral decrease and pulmonary homing of CD4 + CD45RO+ helper memory T cells in cystic fibrosis. Respir Med. 2002;96(2):87-94.
12. Hubeau C, Lorenzato M, Couetil JP, Hubert D, Dusser D, Puchelle E, et al. Quantitative analysis of inflammatory cells infiltrating the cystic fibrosis airway mucosa. Clin Exp Immunol. 2001;124(1):69-76.
13. Kerem E, Reisman J, Corey M, Canny GJ, Levison H. Prediction of mortality in patients with cystic fibrosis. N Engl J Med. 1992;326(18):1187-91.
14. Rosenfeld M, Davis R, FitzSimmons S, Pepe M, Ramsey B. Gender gap in cystic fibrosis mortality. Am J Epidemiol. 1997;145(9):794-803.
15. Harness-Brumley CL, Elliott AC, Rosenbluth DB, Raghavan D, Jain R. Gender differences in outcomes of patients with cystic fibrosis. J Womens Health (La). 2014;23(12):1012-20.
16. Olesen HV, Pressler T, Hjelte L, Mared L, Lindblad A, Knudsen PK, et al. Gender differences in the Scandinavian cystic fibrosis population. Pediatr Pulmonol. 2010;45(10):959-65.
17. Brusselle GG, Demoor T, Bracke KR, Brandsma CA, Timens W. Lymphoid follicles in (very) severe COPD: beneficial or harmful? Eur Respir J. 2009;34(1):219-30.
18. Yadava K, Marsland BJ. Lymphoid follicles in chronic lung diseases. Thorax. 2013;68(6):597-8.
19. Sweezey NB, Ratjen F. The cystic fibrosis gender gap: potential roles of estrogen. Pediatr Pulmonol. 2014;49(4):309-17.
20. Decraene A, Willems-Widyastuti A, Kasran A, De BK, Bullens DM, Dupont LJ. Elevated expression of both mRNA and protein levels of IL-17A in sputum of stable Cystic Fibrosis patients. Respir Res. 2010;11:177.
21. McAllister F, Henry A, Kreindler JL, Dubin PJ, Ulrich L, Steele C, et al. Role of IL-17A, IL-17F, and the IL-17 receptor in regulating growth-related oncogene-alpha and granulocyte colony-stimulating factor in bronchial epithelium: implications for airway inflammation in cystic fibrosis. J Immunol. 2005;175(1):404-12.
22. Wang Y, Cela E, Gagnon S, Sweezey NB. Estrogen aggravates inflammation in Pseudomonas aeruginosa pneumonia in cystic fibrosis mice. Respir Res. 2010;11:166.
23. Chotirmall SH, Greene CM, Oglesby IK, Thomas W, O'Neill SJ, Harvey BJ, et al. 17Beta-estradiol inhibits IL-8 in cystic fibrosis by up-regulating secretory leucoprotease inhibitor. Am J Respir Crit Care Med. 2010;182(1):62-72.
24. Regamey N, Tsartsali L, Hilliard TN, Fuchs O, Tan HL, Zhu J, et al. Distinct patterns of inflammation in the airway lumen and bronchial mucosa of children with cystic fibrosis. Thorax. 2012;67(2):164-70.